Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening

Cancer

Volumn 118, Issue 23, 2012, Pages 5728-5732

  Yen, Amy Ming Fang ^a   Duffy, Stephen W ^b   Chen, Tony Hsiu Hsi ^c   Chen, Li Sheng ^a   Chiu, Sherry Yueh Hsia ^d   Fann, Jean Ching Yuan ^e   Wu, Wendy Yi Ying ^c   Su, Chiu Wen ^c   Smith, Robert A ^f   Tabár, Lászlo ^g  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e KAINAN UNIVERSITY   (Taiwan)

^f AMERICAN CANCER SOCIETY   (United States)

^g FALUN HOSPITAL   (Sweden)

Author keywords

breast neoplasms; mammography; overdiagnosis; randomized trials; screening; Sweden

Indexed keywords

ACTIVE STUDY POPULATION; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PASSIVE STUDY POPULATION; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SWEDEN;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED; SWEDEN;

EID: 84869496808     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27580     Document Type: Article

References (12)

1. Duffy SW, Tabar L, Olsen AH, et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen. 2010; 17: 25-30.
2. Jørgensen KJ, Gøtzsche PC,. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ. 2009; 339: b2587.
3. Puliti D, Zappa M, Miccinesi G, Falini P, Crocetti E, Paci E,. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer. 2009; 45: 3166-3171.
4. Zahl PH, Strand BH, Maehlen J,. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ. 2004; 328: 921-924. (Pubitemid 38496981)
5. Tabár L, Vitak B, Chen TH, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011; 260: 658-663.
6. Moss S,. Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res. 2005; 7: 230-234. (Pubitemid 41387438)
7. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP,. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ. 2006; 332: 689-692.
8. Duffy S, Lynge E, Jonsson O,. Reply: estimation of lead-time and overdiagnosis in breast cancer screening. Br J Cancer. 2009; 100: 220.
9. Tabár L, Fagerberg G, Duffy SW, Day NE, Gad A, Gröntoft O,. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am. 1992; 30: 187-210.
10. Breslow NE, Day NE,. Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC Sci Publ. 1987;(82): 1-406.
11. Welch HG, Black WC,. Overdiagnosis in cancer. J Natl Cancer Inst. 2010; 102: 605-613.
12. Duffy SW, Agbaje O, Tabar L, et al. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res. 2005; 7: 258-265. (Pubitemid 41830164)